261 related articles for article (PubMed ID: 17936533)
41. Trends in antimicrobial susceptibility of Escherichia coli isolates from urology services in The Netherlands (1998-2005).
Nys S; Terporten PH; Hoogkamp-Korstanje JA; Stobberingh EE;
J Antimicrob Chemother; 2008 Jul; 62(1):126-32. PubMed ID: 18417487
[TBL] [Abstract][Full Text] [Related]
42. Antimicrobial susceptibilities of Pasteurella strains isolated from humans.
Lion C; Conroy MC; Carpentier AM; Lozniewski A
Int J Antimicrob Agents; 2006 Apr; 27(4):290-3. PubMed ID: 16564680
[TBL] [Abstract][Full Text] [Related]
43. Comité de l'Antibiogramme de la Société Française de Microbiologie report 2003.
Members of the SFM Antibiogram Committee
Int J Antimicrob Agents; 2003 Apr; 21(4):364-91. PubMed ID: 12672587
[TBL] [Abstract][Full Text] [Related]
44. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
45. [Interest of the disk diffusion method for screening Clostridium difficile isolates with decreased susceptibility to antibiotics].
Poilane I; Bert F; Cruaud P; Nicolas-Chanoine MH; Collignon A
Pathol Biol (Paris); 2007 Nov; 55(8-9):429-33. PubMed ID: 17905536
[TBL] [Abstract][Full Text] [Related]
46. Relationship between susceptibility to antimicrobials and virulence factors in paediatric Escherichia coli isolates.
Arisoy M; Rad AY; Akin A; Akar N
Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S4-8. PubMed ID: 17959360
[TBL] [Abstract][Full Text] [Related]
47. A new antimicrobial susceptibility testing method of Escherichia coli against ampicillin by MSPQC.
He F; Zhou J
J Microbiol Methods; 2007 Mar; 68(3):563-7. PubMed ID: 17175051
[TBL] [Abstract][Full Text] [Related]
48. Antimicrobial resistance in Escherichia coli and Pseudomonas aeruginosa from Intensive Care Units in The Netherlands, 1998-2005.
Oudhuis GJ; Verbon A; Hoogkamp-Korstanje JA; Stobberingh EE;
Int J Antimicrob Agents; 2008 Jan; 31(1):58-63. PubMed ID: 17961989
[TBL] [Abstract][Full Text] [Related]
49. Effect of two balanced salt solutions on the bioavailability of ofloxacin and ciprofloxacin.
Osato MS
Adv Ther; 1999; 16(5):200-9. PubMed ID: 10915395
[TBL] [Abstract][Full Text] [Related]
50. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
Jacobs E; Dalhoff A; Korfmann G
Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
[TBL] [Abstract][Full Text] [Related]
51. Effect of subminimal inhibitory concentrations of three fluoroquinolones on adherence of uropathogenic strains of Escherichia coli.
Baskin H; Doğan Y; Bahar IH; Yuluğ N
Int J Antimicrob Agents; 2002 Jan; 19(1):79-82. PubMed ID: 11814773
[TBL] [Abstract][Full Text] [Related]
52. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
[TBL] [Abstract][Full Text] [Related]
53. In vivo selection of an Escherichia coli isolate highly resistant to ciprofloxacin and ceftazidime: role of a 4-bp duplication in acrR and ampC overexpression.
Corvec S; Lepelletier D; Reynaud A; Dauvergne S; Giraudeau C; Caroff N
Int J Antimicrob Agents; 2008 Aug; 32(2):196-8. PubMed ID: 18571906
[No Abstract] [Full Text] [Related]
54. [Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital].
Akyar I
Mikrobiyol Bul; 2008 Oct; 42(4):713-5. PubMed ID: 19149097
[TBL] [Abstract][Full Text] [Related]
55. Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan.
Hung KH; Sheu BS; Chang WL; Wu HM; Liu CC; Wu JJ
Helicobacter; 2009 Feb; 14(1):61-5. PubMed ID: 19191898
[TBL] [Abstract][Full Text] [Related]
56. Changes in minimum inhibitory concentration of levofloxacin for Escherichia coli strains isolated from urine samples in mainland China, 2004 to 2014.
Li Y; Zheng B; Xue F; Zhu SN; Lyu Y
J Microbiol Immunol Infect; 2017 Jun; 50(3):390-392. PubMed ID: 27593098
[TBL] [Abstract][Full Text] [Related]
57. [Acute pyelonephritis in adults: for a unified patient care].
L'Huillier Y; Jobé C; Emonet S; Defabiani N; Gobin N; Fournier J
Rev Med Suisse; 2019 Sep; 15(661):1545-1550. PubMed ID: 31496187
[TBL] [Abstract][Full Text] [Related]
58. Concentrations in plasma, urinary excretion and bactericidal activity of levofloxacin (500 mg) versus ciprofloxacin (500 mg) in healthy volunteers receiving a single oral dose.
Wagenlehner FM; Kinzig-Schippers M; Sörgel F; Weidner W; Naber KG
Int J Antimicrob Agents; 2006 Dec; 28(6):551-9. PubMed ID: 17101261
[TBL] [Abstract][Full Text] [Related]
59. Anti-microbial resistance stratified by risk factor among Escherichia coli strains isolated from the urinary tract at a rural clinic in Central India.
Chatterjee B; Kulathinal S; Bhargava A; Jain Y; Kataria R
Indian J Med Microbiol; 2009; 27(4):329-34. PubMed ID: 19736402
[TBL] [Abstract][Full Text] [Related]
60. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.
Koksal F; Ak K; Kucukbasmaci O; Samasti M
Chemotherapy; 2009; 55(4):293-7. PubMed ID: 19521075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
